“If successful, we believe this therapy could help reduce severity of illness among a broad population of patients,” Rod MacKenzie, Pfizer's chief development officer, said in a statement.
Source
First Patient Gets Dose in Pfizer’s Oral COVID-19 Drug Trial
![](https://biz2biz.com/wp-content/uploads/2022/03/1630524458-shutterstock-1983344543-1568x1045.jpg)